|Year : 2016 | Volume
| Issue : 46 | Page : 159-164
Reversed phase high-performance liquid chromatographic ultra-violet (photo diode array) quantification of oleanolic acid and its isomer ursolic acid for phytochemical comparison and pharmacological evaluation of four Leucas species used in ayurveda
Pushpendra Kumar Shukla, Ankita Misra, Sharad Srivastava, Ajay K. S. Rawat
Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow, Uttar Pradesh, India
|Date of Submission||26-Oct-2015|
|Date of Decision||07-Dec-2015|
|Date of Web Publication||11-May-2016|
Pharmacognosy and Ethnopharmacology Division, CSIR-National Botanical Research Institute, Lucknow - 226 001, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Content: Different Leucas species are well known as “Dronpushpi,” a well-known herb of Ayurveda, used in the treatment of various ailments. Objective: Evaluation of four industrially important Leucas species for their in vitro antidiabetic potential and radical scavenging effect along with high-performance liquid chromatographic quantification of the bioactive triterpenes. Materials and Methods: The quantification of triterpenes was carried out on C-18 column with acetonitrile and water (90:10) as the solvent system at a detection wavelength of 210 nm. In vitro antidiabetic activity was evaluated by α-amylase inhibition assay based on starch–iodine and 3,5 dinitrosalicylic acid (DNS) method. Antioxidant activity was calculated by five different models, namely total phenolic and total flavonoid content, free radical scavenging activity by 1-1-diphenyl-2-pic-rylhydrazyl (DPPH), ferric-reducing power assay, and the total antioxidant capacity. Results: Maximum concentration of oleanolic acid was found in Leucas cristata, followed by Leucas mollissima, Leucas Aspera, and Leucas biflora. Ursolic acid was highest in L. mollissima and then in L. biflora, L. cristata, and L. aspera, respectively. In in vitro antidiabetic activity, IC50of L. aspera (1.56 ± 0.01 mg/ml) and L. mollissima (0.75 ± 0.005 mg/ml) were found to be highest in DNS and iodine starch assay. IC50in DPPH assay ranges from 0.6 ± 0.011 to 1.68 ± 0.011 mg/ml. Antioxidant capacity follows the order; L. aspera > L. mollissima > L. biflora > L. cristata. Conclusion: Promising activities were observed in targeted species, thus L. mollissima, L. biflora, and L. cristata can be used alternatively as a substitute to L. aspera.
- Physicochemical parameters are within the limit as per the Ayurvedic Pharmacopoeia of India
- Maximum concentration of oleanolic acid was found in Leucas cristata; however, ursolic acid was highest in Leucas mollissima
- In vitro antidiabetic activity of Leucas aspera and L. mollissima was found to
- be heighest as compared to other species. However, antioxidant capacity is almost similar in targeted species.
- Promising activities were observed in all the species, thus L. mollissima, Leucas biflora, and L. cristata can be used alternatively as a substitute to L. aspera.
Keywords: Dronpushpi, in vitro antidiabetic activity, oleanolic acid, ursolic acid
|How to cite this article:|
Shukla PK, Misra A, Srivastava S, Rawat AK. Reversed phase high-performance liquid chromatographic ultra-violet (photo diode array) quantification of oleanolic acid and its isomer ursolic acid for phytochemical comparison and pharmacological evaluation of four Leucas species used in ayurveda. Phcog Mag 2016;12, Suppl S2:159-64
|How to cite this URL:|
Shukla PK, Misra A, Srivastava S, Rawat AK. Reversed phase high-performance liquid chromatographic ultra-violet (photo diode array) quantification of oleanolic acid and its isomer ursolic acid for phytochemical comparison and pharmacological evaluation of four Leucas species used in ayurveda. Phcog Mag [serial online] 2016 [cited 2020 May 26];12, Suppl S2:159-64. Available from: http://www.phcog.com/text.asp?2016/12/46/159/182173
| Introduction|| |
Leucas species (Lamiaceae) collectively recognized as “Dronpushpi,” a well-known herb of ayurvedic systems of medicines is used for cough, cold, diarrhea, inflammatory skin disorders, and several other ailments. The genus comprises about 80 species and the highest diversity has been found in East Africa. Among them, 43 species are available in India  as annual or perennial herbs. Leucas aspera (wild) is the most common species with immense medicinal values such as ulcer protective, antifungal, antioxidant, antimicrobial, antinociceptive, and cytotoxic activity.Leucas biflora (Vahl.) is a two-flowered perennial herb with nodal roots and many branches arise from a woody root stock. As ethnic medicine in Northern India, the mature leaf decoction is used in conjunctivitis.Leucas cristata (Roth.) Spreng, commonly known as gumma, is found abundantly in roadside areas as a weed, especially in rainy season. It possesses stimulant, laxative, diaphoretic, antiseptic, anthelmintic, insecticidal, germicidal, fungicidal, hypolipidemic, hypoglycemic, antiprotozoal, expectorant, and anti-pyretic properties. Foliage of Leucas mollissima Wall. ex Benth. is used in treating headache. The decoction is used orally to treat diabetes mellitus, hepatitis, and is effective in liver diseases.
A variety of chemical markers have been isolated from the Leucas species, which include terpenes, fatty acids, steroids, lignans, flavonoids, coumarins, various aliphatic long-chain compounds, phytol, salicylic acid, and caffeic acid. Several recent reports suggested the preventive role of triterpene oleanolic acid and its isomer, ursolic acid in the treatment of type-2 diabetes and other associated complications, namely nonalcoholic fatty liver disease, nephropathy, retinopathy, and atherosclerosis. The antidiabetic potential of these triterpene isomers is mediated due to target signaling of molecules that increase insulin signal transduction; reduce inflammatory and oxidative stress signaling., The targeted species of Leucas are widely available in Northern and Central part of India and a review of literature suggested that L. aspera is the most utilized one. The present study includes comparative phytochemical investigation along with the evaluation of in vitro antidiabetic potential. The antioxidant potential was also estimated to explain the radical scavenging effect among them, as this is one of the major underlying causes of diabetes. Oleanolic acid and its isomer ursolic acid were also quantified in targeted species to authenticate their use in the management of diabetes. This also prospects for identification of an alternative/substitute of commercially exploited species, i.e. L. aspera.
| Materials and Methods|| |
Oleanolic acid (≥97% high-performance liquid chromatographic [HPLC]), ursolic acid (≥97% HPLC), ascorbic acid (≥97%), quercetin (≥97%), rutin (≥95%), 1-1-diphenyl-2-pic-rylhydrazyl (≥99%, DPPH), and butylated hydroxytoluene were purchased from Sigma-Aldrich. HPLC grade solvents, namely acetonitrile, methanol, water, and all other solvents/chemicals (AR grade) were purchased from Merck, Mumbai, India.
Aerial part of four Leucas species, namely L. aspera (LWG No. 254029), L. biflora (LWG No. 254030), L. cristata (LWG No. 254031), and L. mollissima (LWG No. 254033) were collected from Tendukheda forest, Tamiya, Madhya Pradesh, India, during September–October. Samples were authenticated by Dr. Sharad Srivastava, Scientist, Pharmacognosy Division, CSIR-NBRI, and voucher specimens were deposited in institute's herbarium. Collected samples were washed, shade dried, and powdered for further studies.
Preparation of extract
The dried, aerial parts of Leucas spp. were grinded (lab grinder) and sieved through 40 mesh (up to 500 mm) to obtain fine powder. About 100 g of powdered sample was defatted with petroleum ether and then treated with methanol (ethanol stabilized) through Soxhlet extraction, until complete exhaustion of sample (7 days; 27 ± 2°C). The pooled extracts were filtered (Whatman No. 1 filter paper), concentrated in rotary evaporator under controlled conditions (50°C, 40 mbar), and finally lyophilized extracts were quantified.
Physicochemical and phytochemical characterization
Physicochemical parameters, namely moisture content, total ash, acid insoluble ash, and extractive values (hexane, alcohol, and water-soluble extractives), were evaluated and quantified. Phytochemical estimation of various primary and secondary metabolites, i.e. sugar, starch, phenolic, flavonoid, and tannin  was also done as per the standard protocols.
High-performance liquid chromatographic quantification of oleanolic acid and its isomer ursolic acid in Leucas species
Reversed phase-HPLC ultra-violet-2996 (Cyber Lab, LC 100, USA) was used for the qualitative and quantitative analysis of analytes. Chromatographic separation was performed on phenomenex C18 column (250 mm × 4.6 mm, 5.0 µm,) with C18 guard column in isocratic mode via binary mobile phase consisting of acetonitrile: Methanol (90:10) at 0.8 ml/min. Mobile phases were duly filtered through 0.22 µm millipore filter and degassed ultrasonically for 15 min before delivered to column for separation and run time was 30 min. Data acquisitions were performed using ChromeStation software. The injection volume was 25 µl for standard and sample. Detection was done at a wavelength is 210 nm.
In vitro (alpha amylase inhibition assay) antidiabetic activity
Starch–iodine color assay
Assay was carried out with slight modification based on the starch–iodine test. Methanol extract (500 μL) of varied concentrations were added to 500 μL of 0.02 M sodium phosphate buffer (pH 6.9 containing 6 mM sodium chloride) containing 0.04 units of α-amylase solution and were incubated at 37°C for 10 min, then 500 μL soluble starch (1% w/v) was added to each reaction well and again incubated at 37°C for 15 min. 1 M HCl (20 μL) was added to stop the enzymatic reaction, followed by the addition of 100 μL of iodine reagent (5 mM I2 and 5 mM KI). The color change was noted and the absorbance was read at 620 nm on a micro plate reader. The control reaction representing 100% enzyme activity did not contain any plant extract to eliminate the absorbance produced by plant extract; appropriate extract controls without the enzyme were also included. Acarbose is used as a positive control and the inhibition of enzyme activity was calculated as:
Inhibition of enzyme activity (%) = (C − S)/C × 100
Where S is the absorbance of the sample and C is the absorbance of blank (no extract).
3,5-dinitrosalicylic acid method
The inhibition assay was performed using 3,5-dinitrosalicylic acid (DNS) method. Methanol extract (500 μL) of varied concentrations were added to 500 μL of 0.02 M sodium phosphate buffer (pH 6.9 containing 6 mM sodium chloride) containing 0.04 units of α-amylase solution and were incubated at 37°C for 10 min, followed by addition of 500 μL of a 1% starch solution (0.02 M sodium phosphate buffer, pH 6.9) in all the test tubes. The reaction was stopped with 1.0 ml of DNS reagent. The test tubes were then incubated in a boiling water bath for 5 min and cooled to room temperature. The reaction mixture was then diluted after adding 10 ml of distilled water and absorbance was measured at 540 nm. The control samples were also prepared accordingly without any plant extracts and were compared with the test samples containing various concentrations of the plant extracts. Acarbose is used as a positive control and results were expressed as % inhibition calculated using the formula.
Inhibition activity (%) = Abs (control) − Abs (extract) × 100/Abs (control)
In vitro antioxidant activity
Total flavonoid  and phenolic  content were expressed in terms of mg/g of quercetin equivalent (QE) and mg/g gallic acid equivalent (GAE) based on calibration curve of quercetin and gallic acid as standard. The anti-oxidant potential was analyzed via DPPH radical scavenging assay, ferric reducing power assay, and total antioxidant capacity.
Results were expressed as mean ± standard deviation. Linear regression analysis was carried out for standards to calculate total phenolic and flavonoid content. IC50 values were obtained by GraphPad Prism 5 software (San Diego, CA, USA). One-way ANOVA followed by Student's t-test (P < 0.01) was used to find the significance of in vitro antidiabetic and antioxidant assays.
| Results and Discussion|| |
Physicochemical and phytochemical studies
Physicochemical parameters of L. aspera, L. biflora, L. cristata, and L. mollissima were studied and compared quantitatively [Figure 1]. The study reveals that alcohol soluble extractive was highest in all the four species as compared to other extractive values; L. biflora shows the maximum, i.e. 24%. However, hexane and water-soluble extractive varies from 3.25–4.25% to 9.75–12.25%, respectively; however, moisture content was maximum in L. cristata (6.6%). Total ash and acid insoluble ash ranges between 3.27–5.05% and 0.75–2.4%, respectively. The values are observed within the specified limit of API.
|Figure 1: Physico-chemical parameter of Leucas species (values are mean, n = 3)|
Click here to view
Analysis of phytochemicals [Figure 2] reveals that starch was found abundantly in the four species than other metabolites, and concentration ranges from 0.448% to 0.664%. Sugar, tannin, phenolic, and flavonoid content vary considerably among the species, i.e., 0.076–0.053%, 0.2–0.4%, 0.0015–0.018%, and 0.0014–0.0079%, respectively. It was observed that the species were not significantly different in the content of phytochemicals.
|Figure 2: Quantitative estimation of various phytochemicals in Leucas species (values are mean, n = 3)|
Click here to view
High-performance liquid chromatographic quantification of oleanolic acid and its isomer
Quantification of targeted chemical marker, namely oleanolic and ursolic acid in different Leucas species was carried out on the basis of calibration curve of standards. Five dilutions of standard were used in a concentration range of 0.125–1 mg/ml and various calibration values were obtained [Table 1]. Maximum concentration of oleanolic acid was found in L. cristata, followed to L. mollissima, L. aspera, and L. biflora. Ursolic acid was highest in L. mollissima, and then in L. biflora, L. cristata, and L. aspera, respectively [Figure 3], [Figure 4], [Figure 5], [Figure 6] and [Table 2].
|Table 1: Statistical analysis of calibration curves in high-performance liquid chromatography determination of triterpenes chemical markers |
Click here to view
|Figure 3: High-performance liquid chromatographic ultra-violet chromatogram of Leucas aspera|
Click here to view
|Figure 4: High-performance liquid chromatographic ultra-violet chromatogram of Leucas cristata|
Click here to view
|Figure 5: High-performance liquid chromatographic ultra-violet chromatogram of Leucas mollissima|
Click here to view
|Figure 6: High-performance liquid chromatographic ultra-violet chromatogram of Leucas biflora|
Click here to view
|Table 2: Quantification (%) of oleanolic acid and its isomer ursolic acid in four species of Leucas |
Click here to view
In vitro biological assays
In vitro antidiabetic activity
In vitro antidiabetic activity was evaluated by α-amylase inhibition assay based on starch–iodine and DNS method. Data of starch–iodine method reveal that activity increases linearly with concentration, i.e., 0.1–0.5 mg/ml of tested plant extract [Figure 7]a. IC50 follows the order, L. mollissima (0.75 ± 0.005) >L. aspera (0.6 ± 0.01) >L. biflora = L. cristata (0.5 ± 0.01), whereas acarbose exhibit IC50 at <25 µg/ml. Results of α-amylase inhibition by DNS show that with increase in the concentration of inhibitors, degradation of starch reduces and thus indicating the inhibition of enzyme activity. The inhibition (%) by Leucas species varies from 9.09% to 87.95% [Figure 7]b and acarbose exhibits 36.67–95.74% inhibition at a concentration of 10–200 µg/ml, respectively. IC50 of acarbose was observed at 32 ± 0.01 µg/ml, whereas within the Leucas species, IC50 was maximum in L. aspera (1.56 ± 0.01 mg/ml), followed by L. biflora (0.43 ± 0.05), L. mollissima (0.30 ± 0.01), and then L. cristata (0.24 ± 0.01) [Table 3]. Thus indicating that L. cristata exhibits the most promising activity. However, the inhibitors were significantly indifferent (P < 0.01) from each other. The bioactive potential of Leucas species is suspected due to the presence of identified markers in synergy with other phytomolecules.
|Figure 7: (a) Anti-diabetic assay by starch-iodine color reagent. (b) Anti-diabetic assay by 3,5 dinitrosalicylic acid method color reagent|
Click here to view
|Table 3: IC50 of Leucas species obtained from in-vitro antidiabetic assay |
Click here to view
In vitro antioxidant activity
Antioxidant activity of Leucas species were calculated by five different models having variable mechanism of action. Polyphenolic content, namely total phenolic and flavonoid content were estimated [Table 4], total phenolic content was highest in L. aspera (5.55 ± 0.05 mg/g GAE), followed by L. mollissima (0.97 ± 0.005 mg/g GAE), L. biflora (0.87 ± 0.005 mg/g GAE), and then L. cristata (0.30 ± 0.057 mg/g GAE). However, flavonoid content varies from 0.28 ± 0.005 to 1.59 ± 0.005 mg/g QE. The reducing power assay of extract served as a significant indicator of its potentiality as a reducing agent, which in turn signifies its anti-oxidant activity. Result showed that the reducing power of four species (methanolic extract) increases linearly with increase in concentration, i.e. L. aspera, L. biflora, L. cristata, and L. mollissima having regression coefficient (r2) of 0.983, 0.980, 0.888, and 0.990, respectively. This is found similar to standards, i.e. ascorbic acid (0.998), quercetin (0.997), and rutin (0.998).
Free radical scavenging activity of DPPH is most widely used for screening of medicinal plants having anti-oxidant activity. The scavenging effect of DPPH radical on four Leucas species was concentration-dependent and varied among samples as well as standards (ascorbic acid, quercetin, and rutin) [Figure 8]. Ascorbic acid exhibits the maximum inhibition of 77.57% (IC50 at 3.86 ± 0.057 µg/ml), which is followed by quercetin and rutin having inhibition of 72.43 (IC50 at 5.93 ± 0.115 µg/ml) and 71.48 (IC50 at 6.8 ± 0.173 µg/ml), respectively. Leucas species, namely L. aspera, L. biflora, L. cristata, and L. mollissima have IC50 at 1.68 ± 0.011, 0.66 ± 0.05, 1.25 ± 0.005, and 0.6 ± 0.011 mg/ml, respectively [Table 5]. However, the IC50 of samples was statistically different (P < 0.01) than standard.
|Figure 8: Percentage inhibition of radical scavenging activity of Leucas species in 1-1-diphenyl-2-pic-rylhydrazyl assay|
Click here to view
|Table 5: IC50 value of Leucas spp. in 1-1-diphenyl-2-pic-rylhydrazyl radical scavenging assay |
Click here to view
The total antioxidant capacity of Leucas (methanolic extract) was measured by phosphor-molybdenum method based on regression analysis of ascorbic acid, having regression equation (y = 4.804x + 0.136) and coefficient; r2 = 0.987. Data shows that maximum total anti oxidant capacity was observed in L. aspera (0.411 ± 0.0005 mg/g ASE), followed by L. mollissima (0.172 ± 0.001 mg/g ASE), L. biflora (0.139 ± 0.001 mg/g ASE) and L. cristata having 0.131 ± 0.005 mg/g of ascorbic acid equivalent [Figure 9]. It is observed that all the four species exhibit promising in vitro antioxidant activity and there is insignificant difference between them.
|Figure 9: Total antioxidant activity (g/g) of ascorbic acid equivalent in Leucas species|
Click here to view
| Conclusion|| |
From the above study, it is inferred that bioactive triterpenes, namely oleanolic acid and ursolic acid are present in significant amount in all the evaluated species and thus exhibiting promising antidiabetic and antioxidant potential. Maximum concentration of oleanolic acid was found in L. cristata; however, ursolic acid was highest in L. mollissima.In vitro anti-diabetic studies showed that L. aspera (1.56 ± 0.01 mg/ml) and L. mollissima (0.75 ± 0.005 mg/ml) have significant potential. It is also evident that the potentiality of all the species as natural antioxidants and anti-diabetic were also comparable among each and hence the less explored species, i.e. L. biflora, L. cristata, and L. mollissima can be used as a substitute by herbal industries for L. aspera, which is widely recognized and exploited in various ayurvedic formulations by the name of “Dronpushpi. ”
The authors are thankful to the Director of CSIR-NBRI for providing facilities and encouragement throughout the work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ryding O. Phylogeny of the Leucas
). Syst Bot 1998;23:235-47.
Augustine BB, Pitta S, Lahkar M, Suvakanta D, Samudrala PK, Thomas JM. Ulcer protective effect of Leucas aspera
in various experimental ulcer models. Asian Pac J Trop Dis 2014;4:S395.
Mukerjee SK. A revision of the labiatae of the Indian empire. Records of Botanical Survey of India. Vol. 14. Manager of Publications; 1940. p. 1-205.
Prajapati MS, Patel JB, Modi K, Shah MB. Leucas aspera
: A review. Pharmacogn Rev 2010;4:85-7.
Koushik M, Datta BK. Leucas
biflora (Vahl) R. Br. (Lamiaceae
): A new distributional record and its less known ethno-medicinal usage from Tripura. Indian J Tradit Knowl
Ansari MY, Wadud A. Pharmacognostical evaluation of roots of gumma, (Leucas cristata
(Roth.) Spreng). Indian J Nat Prod Res 2013;L4:88-95.
Das SN, Patro VJ, Dinda SC. A review: Ethnobotanical survey of genus Leucas
. Pharmacogn Rev 2012;6:100-6.
Chouhan HS, Singh SK. A review of plants of genus Leucas
. J Pharmacogn Phytother 2011;3:13-26.
Basarkar UG. Phytol – A chemical constituent of Leucas aspera
through HPTLC. Am Int J Res Form Appl Nat Sci 2014;8:44-6.
Begum P, Wang Y, Fugetsu B. Biologically active compounds from Leucas lavandulaefolia
. Int J Pharm Sci Res 2015;6:1013-21.
Camer D, Yu Y, Szabo A, Huang XF. The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications. Mol Nutr Food Res 2014;58:1750-9.
Castellano JM, Guinda A, Delgado T, Rada M, Cayuela JA. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes 2013;62:1791-9.
Anonymous. The Ayurvedic Pharmacopoeia of India. Vol. 165. New Delhi: Government of India, Ministry of Health and Family Welfare; 1989. p. 7-18.
Bray HG, Thorpe WV. Analysis of phenolic compounds of interest in metabolism. Methods Biochem Anal 1954;1:27-52.
Ordonez AA, Gomez JD, Vattuone MA, Isla MI. Antioxidant activities of Sechium edule
(Jacq.) Swart extracts. Food Chem 2006;97:452-8.
Anonymous. Official Methods of Analysis of Association of Official Analytical Chemists (AOAC). Virginia, US: Virginia, AOAC International;1984.
Xiao Z, Storms R, Tsang A. A quantitative starch-iodine method for measuring alpha-amylase and glucoamylase activities. Anal Biochem 2006;351:146-8.
Miller GL. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem 1959;31:426-8.
Liyana-Pathirana CM, Shahidi F. Antioxidant activity of commercial soft and hard wheat (Triticum aestivum
L.) as affected by gastric pH conditions. J Agric Food Chem 2005;53:2433-40.
Kumaran A, Karunakaran RJ. In vitro
antioxidant activities of methanol extract of Phyllanthus
species from India. Lebens Wiss Technol 2007;40:344-52.
Prieto P, Pineda M, Aguilar M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: Specific application to the determination of Vitamin E. Anal Biochem 1999;269:337-41.
| Authors|| |
Dr. Sharad Srivastava, is Principal Scientist in Pharmacognosy Division at CSIR-National Botanical Research Institute; Lucknow, India. He has made significant contributions to quality control of crude drugs/products, chemotaxonomy, bio-prospection, and natural product development, and have developed quality parameters of single crude drugs (more than 70 medicinal plants) and also identified biomarkers for their quality control. He has contributed 30 monographs of single herbal drugs in Ayurvedic Pharmacopoeia of India. He has 115 publications in peer-reviewed journals, 17 patents, and developed some technologies/formulations, few has already been transferred to industry.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]